Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

Life versus death.

Moss AJ.

Circulation. 2008 Apr 15;117(15):1912-3. doi: 10.1161/CIRCULATIONAHA.108.770156. No abstract available.

2.

Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.

Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S.

Circulation. 2008 Apr 15;117(15):1918-26. doi: 10.1161/CIRCULATIONAHA.107.742155. Epub 2008 Apr 7.

3.

Implantable cardioverter-defibrillator therapy and the total burden of sudden cardiac death.

Huikuri HV.

Europace. 2009 Dec;11(12):1574. doi: 10.1093/europace/eup366. No abstract available.

PMID:
19933771
4.

Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implantable cardioverter-defibrillators.

Bunch TJ, Hohnloser SH, Gersh BJ.

Circulation. 2007 May 8;115(18):2451-7. Review. No abstract available.

5.

The implantable cardioverter-defibrillator minimalist: an approach to patient follow-up and management of implantable defibrillators.

Sweeney MO.

Circulation. 2012 Jul 17;126(3):369-77. doi: 10.1161/CIRCULATIONAHA.111.023887. No abstract available.

6.

Late implantation of an implantable cardioverter-defibrillator in a patient with Brugada syndrome prevented sudden arrhythmic death.

Mok NS, Chan NY, Choi YC.

Int J Cardiol. 2003 Feb;87(2-3):269-71. No abstract available.

PMID:
12559549
7.

Epidemiological impact of microvolt T-wave alternans in sudden cardiac death primary prevention.

Daccarett M, Serafimovski N, Machado C.

Int J Cardiol. 2007 Jun 25;119(1):127-8; author reply 129-30. Epub 2006 Oct 16. No abstract available.

PMID:
17049385
8.

The appropriate evaluation of the patient at risk for sudden death from ventricular arrhythmias.

Green MS, Ricci J, Wolfe K.

Can J Cardiol. 2000 Jun;16 Suppl C:13C-5C. Review. No abstract available.

PMID:
10887271
10.

Predicting sudden death risk for heart failure patients in the implantable cardioverter-defibrillator age.

Stevenson WG, Epstein LM.

Circulation. 2003 Feb 4;107(4):514-6. No abstract available.

11.

Risk of arrhythmic and nonarrhythmic death in patients with heart failure and chronic kidney disease.

Alsheikh-Ali AA, Trikalinos TA, Ruthazer R, Terrin N, Wong JB, Sarnak MJ, Estes NA 3rd, Kent DM.

Am Heart J. 2011 Jan;161(1):204-209.e1. doi: 10.1016/j.ahj.2010.09.020.

PMID:
21167355
12.

Refining patient selection for primary prevention implantable cardioverter-defibrillator therapy: reeling in a net cast too widely.

Tung R, Swerdlow CD.

Circulation. 2009 Sep 8;120(10):825-7. doi: 10.1161/CIRCULATIONAHA.109.891069. Epub 2009 Aug 24. No abstract available.

13.

Chapter 1. Summary of the CCS Consensus Conference on prevention of sudden death from cardiac arrhythmia.

Connolly SJ, Talajic M.

Can J Cardiol. 2000 Oct;16(10):1298-302. Review. No abstract available.

PMID:
11064304
14.

[Sudden death in a normal heart. Idiopathic ventricular fibrillation. Review of the literature concerning one case].

García Fernández J, Basterra N, Martínez Basterra J, Alvarez V, Ruiz V, Carmona JR, De los Arcos E.

An Sist Sanit Navar. 2003 Jan-Apr;26(1):123-7. Review. Spanish.

15.

The efficacy of implantable cardioverter-defibrillators in heart transplant recipients: results from a multicenter registry.

Tsai VW, Cooper J, Garan H, Natale A, Ptaszek LM, Ellinor PT, Hickey K, Downey R, Zei P, Hsia H, Wang P, Hunt S, Haddad F, Al-Ahmad A.

Circ Heart Fail. 2009 May;2(3):197-201. doi: 10.1161/CIRCHEARTFAILURE.108.814525. Epub 2009 Apr 30.

16.

Defibrillation threshold testing in implantable cardioverter-defibrillators: might less be more than enough?

Curtis AB.

J Am Coll Cardiol. 2008 Aug 12;52(7):557-8. doi: 10.1016/j.jacc.2008.05.016. No abstract available.

17.

[Nursing care for automatic implantable defibrillators].

Pépin A, Samuel B, Kihel A.

Soins. 2006 Jan-Feb;(702 Suppl):S3-5. French. No abstract available.

PMID:
16493932
18.

Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for prevention.

Ye S, Grunnert M, Thune JJ, Stephenson KM, Uno H, Finn PV, McMurray JJ, Velazquez EJ, Califf R, Pfeffer MA, Solomon SD.

Circulation. 2011 Jun 14;123(23):2674-80. doi: 10.1161/CIRCULATIONAHA.110.990655. Epub 2011 May 23.

19.

[Regarding the French Society of Cardiologists' guidelines on the indications for implantable automatic ventricular defibrillators].

Daubert JC.

Arch Mal Coeur Vaiss. 2006 Feb;99(2):93-4. French. No abstract available.

PMID:
16555690
20.

Transvenous implantable cardioverter-defibrillator leads: the weakest link.

Maisel WH.

Circulation. 2007 May 15;115(19):2461-3. No abstract available.

Supplemental Content

Support Center